Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Lot IP10-260411 is 99% pure as verified by HPLC analysis (HPLC with UV detection coupled with mass spectrometry LC-MS)
Assembly of excitatory synapses in the absence of glutamatergic neurotransmission
Originally developed to treat type 2 diabetes, it works by activating GLP-1 and GIP receptors, which regulate blood sugar and appetite control
Whats worse, patients with T2D were observed a decreased expression of GLUT1/2, which reduce intracellular transportation of glucose, thus producing less ATP and impaired insulin releasing
Because microdosing falls outside the dosing schedules studied in clinical trials, doctors say there are still more questions than answers
US$ 22.96
US$ 25.24
US$ 27.23
